ImmuPharma PLC (AIM:IMM) will showcase its pipeline at two leading US healthcare conferences next week as it seeks new partners.
The London-listed drug developer said its chief executive Tim McCarthy, chief operating officer Tim Franklin and chief scientific officer Sebastien Goudreau will attend the JP Morgan Healthcare Conference and the Biotech Showcase in San Francisco from January 12 to 14.
The annual events bring biotechnology groups together with global pharmaceutical companies and investors during a busy period for dealmaking and scientific updates.